Thioredoxin interacting protein plays a pivotal role in several important processes of cardiovascular homeostasis by functioning as a biological sensor for biomechanical and oxidative stress. However, the effects of genetic variants in the modulation of arterial stiffness are unknown. In this scenario, the present study evaluated the relationship between the TXNIP rs7212 polymorphism and arterial stiffness. In the overall sample and in the diabetic group, individuals carrying CG þ GG genotypes had higher PWV values compared with CC genotype group (10.0 vs 9.8 m s
À1
, P ¼ 0.03; 12.3 vs 11.2 m s À1 , P ¼ 0.01; respectively). Our findings indicated that the G allele may contribute to increased arterial stiffness in the Brazilian general population and suggest a possible interaction with diabetes.
Increased central artery stiffness is an important determinant of cardiovascular risk and epidemiological studies reported that increased arterial stiffness predicts mortality and morbidity, independently of other cardiovascular risk factors. 1 The decrease in arterial elasticity may also be a consequence of various pathological processes, 2 inappropriate lifestyle 2 and genetic factors. 3 Thioredoxin interacting protein (TXNIP) is an endogenous inhibitor of the thioredoxin system (TXN), and plays a pivotal role in several important processes of cardiovascular homeostasis by functioning as a biological sensor for biomechanical and oxidative stress. 4 The TXNIP gene, located on the long arm of chromosome 1q21, is modulated by mechanical stimuli from the cardiovascular system, as occurs during pressure-overload cardiac hypertrophy or even physiologic fluid shear stress. 5 Minn et al., in b-cell culture of diabetic mice, demonstrated that the expression of TXNIP is increased and the over-expression of this protein is associated with increased apoptosis of b-cells. 6 Yamawaki et al., using aorta tissue, reported that the expression of TXNIP is reduced in regions with more shear stress, thus leading to an increased activity of the TXN system, and that this may be a possible mechanism involved in vascular dysfunction. 5 In this scenario, the main aim of the present work was to evaluate the relationship between the TXNIP rs7212 polymorphism and arterial stiffness phenotype in the Brazilian general population.
Our study sample was based on a cross-sectional design in the urban population of Vitoria City, Brazil. 7 A sample of 2044 participants of either gender, 25 --64 years of age, was chosen according to the nearest birthday after a random selection of domiciles. Of the 2044 participants invited, 1518 individuals attended the clinic visit and were further evaluated for: anthropologic indices, ethnicity, blood pressure (BP), arterial stiffness and lipid profile. This study was approved by the Committee for research on Human Subjects of the Heart Institute and informed consents were obtained from all participants. Arterial stiffness was measured by carotid-femoral pulse wave velocity (PWV). The validation of this automatic method and its reproducibility has been previously described. 8 TXNIP rs7212 was chosen based on the previous association of this marker with diabetes in the Brazilian population (Ferreira, NE, unpublished results). In the present study it was detected by polymerase chain reactionrestriction fragment length polymorphism assay. A 30 --cycle PCR was carried out using a 10 ml reactive solution containing (10 mM Tris-HCl, pH 9.0; 50 mM KCl; 2.5 mM MgCl 2 ; 100 mM of each dNTP; 0.3 U Taq DNA Polymerase; 5 pmol of each primer; 50 ng of genomic DNA template). PCR products were digested with 1 U of the HaeIII restriction enzyme and visualized by 3% agarose gel electrophoresis. Quality control was assessed by re-genotyping of 40 samples randomly selected and gave identical results in all tests. Statistical analyses were carried out using the SPSS 16.0 software (Chicago, IL, USA), with the level of significance set at Po0.05. Continuous variables were expressed as the mean±s.d. (standard deviation). Univariate and multivariate logistic regression analyses were employed to assess the relationship between TXNIP rs72712 polymorphism and arterial stiffness status with adjustment for the effects of confounding phenotypes. Genotypic frequencies were 69% for CC; 28% for CG and 3% for GG; and frequency of allele G was of 17.5%. Distribution of the genotypes in the overall sample and in the diabetic and non-diabetic groups were in accordance with the Hardy --Weinberg equilibrium (P ¼ 0.09, X 2 ¼ 2.9; P ¼ 0.14,
. Based on our sample size (1518 individuals), allele and genotype frequencies (69% for CC; 28% for CG and 3% for GG; and allele G frequency of 17.5%), and observed PWV sample mean and standard deviation, our study had 80% power to detect an effect of 0.3 or higher in PWV mean value associated with the presence of at least one G allele.
Differences in age, gender, body mass index, systolic BP, diastolic BP, mean BP, pulse pressure, total cholesterol, LDLcholesterol, HDL-cholesterol and triglycerides levels according to genotype groups were not observed (CC vs CG þ GG). However, individuals carrying CG or GG genotypes had higher PWV values compared with individuals carrying CC (10.0 vs 9.8 m s À1 ; P ¼ 0.03, respectively), adjusting for age, MBP and ethnicity ( Table 1) .
The ethnicity distribution according to genotypes was significantly different. However, our analysis remains significant even after adjustment for ethnicity plus potential confounders. In addition, in a stratified analysis for ethnicity, African and Caucasian descents carrying CG þ GG genotypes had higher PWV values compared with CC genotype (10.4 vs 9.3 m s À1 , Po0.01; 9.9 vs 9.6 m s À1 , P ¼ 0.04; respectively), adjusting for age and MBP. Nonetheless, it should be highlighted that it is difficult to completely exclude the participation of these variables in the observed results.
In the diabetic group, individuals carrying CG þ GG genotypes had higher PWV values compared with CC genotype group (12.3 vs 11.2 m s À1 , respectively; P ¼ 0.01), adjusting for age, MBP and ethnicity. However, no difference in PWV values was found in nondiabetic individuals (P ¼ 0.53) (Figure 1 ). Interestingly, after the addition of diabetes in the multivariate model, not only TXNIP genotype was significantly associated with PWV (Po0.001) (adjusted for mean arterial blood pressure), but also a statistically significant interaction term (P ¼ 0.02) between TXNIP and diabetes was also observed.
Studies focusing on TXNIP genetic variants and vascular phenotypes are absent in the literature. Nonetheless, there are few studies involving TXNIP gene polymorphisms and glucose metabolism. 6, 9 To our knowledge, this is the first study linking a TXNIP genetic variant with an arterial stiffness phenotype. Our results showed that individuals carrying the G allele had higher PWV values compared with individuals carrying the CC genotype, even after adjustment for covariates. Interestingly, this association seems to be restricted to diabetic individuals, a pathological condition know to have a dysfunctional TXN system.
It is well established that TXNIP protein has a pivotal role in redox regulation, since its interaction with the TXN system can activate various cellular signaling molecules, as in vascular function and glucose metabolism. 4, 10 Based on this, we suggest that TXNIP rs7212 polymorphism may be associated with significant changes in the vascular bed due to an increased reactive oxygen species production, which are widely associated with diabetes and known to lead to increased arterial stiffness.
11
What is known about this topic TXNIP has a pivotal role in several important processes of cardiovascular homeostasis by functioning as a biological sensor for biomechanical and oxidative stress. TXNIP gene polymorphisms have been associated with dysfunction in glucose metabolism.
What this study adds TXNIP rs7212 polymorphism is associated with arterial stiffness in the general population.
There is a significant interaction between TXNIP genotype and diabetes leading to increased arterial stiffness. 
